Price (USD)68.55 Today's Change0.00 / 0.00% Shares traded9.89k 1 Year change+2.99% Beta-- Data delayed at least 15 minutes, as of Jan 23 2025 19:12 GMT. Participate in the 2025 Stockpicking Contest Long or short five stocks and compete to have the highest return by the end of the...
AstraZeneca PLC AZN:DEU Actions Price (EUR)138.95 Today's Change3.45 / 2.55% Shares traded40.51k 1 Year change+11.34% Beta-- Data delayed at least 15 minutes, as of Feb 06 2025. Find More Stocks Use our equities screener to discover other potential opportunities....
AstraZeneca Stock Forecast, "AZN" Share Price Prediction Charts Is "AstraZeneca PLC" a Good Investment? Current price today: ▲10524.00 GBX (+0.0951%) History Forecast Data Market Q&A Comments Buy CRYPTO Select other stock... Current Price ▲10524.00 GBX 7 Days Forecast Get It Now! 1...
NewsProfileAnalyst Coverage5 Yr. FinancialsDividendsEarningsPrice HistoryEventsInsidersAstraZeneca PLC News Stock Investing News, Analysis and Tips Sep 5, 2023 7:00 AM EDT Is Walgreens so bad it's a buy? Shares slumped on Friday after the company and its CEO agreed to part ways. The pharmacy...
Get AstraZeneca PLC (AZN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
sell a stock. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest amount that a seller is currently willing to sell. The numbers next to the bid/ask are the “size”. The bid size displays the total amount of desired shares ...
UBS analyst Matthew Weston maintained a Sell rating on AstraZeneca (AZN –Research Report) today and set a price target of £113.00. The company’s shares opened today at p12,884.00. Stay Ahead of the Market: Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter...
Shares Outstanding3.1B Public Float3.1B Beta0.52 Rev. per EmployeeN/A P/E Ratio33.82 EPS$2.25 Yield1.99% Dividend$1.03 Ex-Dividend DateFeb 21, 2025 Short Interest15.46M02/14/25 % of Float Shorted0.50% Average Volume5.49M Recent News
Meta Platforms Inc - Ordinary Shares - Class A META 655.58 15.58(2.43%) See Profile Johnson & Johnson JNJ 165.28 0.14(-0.09%) See Profile Pulse Biosciences Inc PLSE 18.51 0.74(4.16%) See Profile Data delayed 15 minutes Stocks Rankings for AZN U.S. News compares companies to their industr...
"Today's announcement reinforces AstraZeneca's long-term commitment to diabetes, a core strategic area for us and an important platform for returning AstraZeneca to growth." (Read more:) While Bristol-Myers' CEO Lamberto Andreotti said the deal would enable the company to move to a more simp...